Pfizer Collaborates with Akzo Nobel over New Antipsychotic
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 42 (Table of Contents)
Published: 3 Dec-2003
DOI: 10.3833/pdr.v2003.i42.843 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Pharmaceutical giant Pfizer entered into a collaboration agreement with Organon to develop asenapine for treating schizophrenia and bipolar disorder...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018